ArticleMolecular therapy. Oncology2024

Point-of-care manufacturing of anti-CD19 CAR-T cells using a closed production platform: Experiences of an academic in Thailand.

Sudjit Luanpitpong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.